DB

Diebold Nixdorf, Incorporated

DBDTechnologyNASDAQ

Software - Application

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.81B
+1.5% YoY
Net Income
$94.6M
+673.3% YoY
EBITDA
$338.3M
+1.0% YoY
Free Cash Flow
$312.0M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20CONFIRMED▼ RSI OverboughtRSI 74.1, above 70, stock may be overbought
Oct 6▲ MACD Positive CrossoverHistogram +0.5474, positive momentum
About Diebold Nixdorf, Incorporated

Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide. The $2.35B market capitalization puts DBD squarely in mid-cap range for its industry. It operates through two segments, Banking and Retail.

Where DBD stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, DBD finished 10.70% below its 150-day moving average ($75.67) and 10.01% below its 200-day moving average ($75.09). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is DBD overbought or oversold?

At the October 20, 2026 close, DBD's RSI(14) was 74.1, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$2.35B
P/E (TTM)22.83
Fwd P/E9.85
EPS$3.03
Beta1.19
52W Change+17.8%
Dividend Yield0.00%
ROE10.9%
Analysis

Diebold Nixdorf, Incorporated carries $1.11B in total debt against $267.2M in cash reserves — debt is roughly 4.1x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $312.0M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 10.9%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.8% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $3.91B (2021) to $3.81B (2025).

Investors considering Diebold Nixdorf, Incorporated should weigh the typical risks associated with DBD's sector, size, and financial profile against their own risk tolerance and investment objectives. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Diebold Nixdorf, Incorporated's trajectory.

Links
More Technology stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms